Influence of genetic polymorphisms in CYP1A2, CYP2C19, CYP3A4, GSTP1, MDR1 and PSMB5 genes in toxicity and response to induction therapy in multiple myeloma patients included in the trial of the Spanish PETHEMA/GEM 05 for newly diagnosed MM elderly patien
Data de publicación
2011Título da revista
Blood
Tipo de contido
Publicación de congreso